MedMira Inc's stock has taken a significant hit, dropping over 14% in today's trading session.
MedMira Inc (MIR.V) is facing a tough day as its stock price has plummeted by 14.29%, closing at CA$0.06. This decline raises concerns among investors about the company's future performance and market position.
Advertisement
MedMira Inc
MIR.V
MIR.V
MedMira Inc
WealthAwesomeMarket cap
$49.12M
52W high
$0.11
52W low
$0.05
1W change
-7.69%
Beta
0.80
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MIR's historical volatility
30-Day Vol
110.3%
Annualized
90-Day Vol
101.7%
Annualized
Trend (90d)
+0.0%
Annualized drift
90d Mean
C$0.06
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.06 | C$0.04 – C$0.09 |
| 60 trading days | C$0.06 | C$0.04 – C$0.10 |
| 90 trading days | C$0.06 | C$0.03 – C$0.12 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should closely monitor MedMira's financial health and market developments, especially after today's significant drop in stock value.
MedMira Inc's stock falls 14.29% today
The drop in stock value reflects investor worries about the company's financial performance and growth prospects.
Bull case
If MedMira can successfully navigate regulatory approvals and expand its market reach, there could be a chance for its stock price to recover.
Bear case
Ongoing financial losses and a lack of significant news might lead to further declines in MedMira's stock, making it a risky investment.
Today's Performance Overview
Advertisement
MedMira Inc's stock fell sharply today, closing down 14.29%. This significant decline raises questions about the company's stability and future growth potential. Investors are advised to consider the implications of this drop, especially given the absence of recent positive news.
Market Reactions and Investor Sentiment
The sharp decline in MedMira's stock price has sparked negative sentiment among investors. With a market cap of about CA$49 million, the company's financial health is under scrutiny. Investors should watch for any upcoming announcements or developments that could impact stock performance. For more insights, check out the latest financial results for MedMira here.
Looking Ahead
As MedMira Inc navigates its current challenges, investors should stay alert. Monitoring the company's progress in regulatory approvals and market expansions will be crucial. For ongoing updates and analysis, keep an eye on MedMira's performance here.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
